Acadian Asset Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $275K | Buy |
|
|||||
|
2025
Q2 | $154K | Sell |
|
|||||
|
2025
Q1 | $19M | Buy |
|
|||||
|
2024
Q4 | $5.76M | Buy |
|
|||||
|
2024
Q3 | $1.15M | Sell |
|
|||||
|
2024
Q2 | $912K | Sell |
|
|||||
|
2024
Q1 | $5.94M | Sell |
|
|||||
|
2023
Q4 | $8.88M | Sell |
|
|||||
|
2023
Q3 | $8.65M | Buy |
|
|||||
|
2023
Q2 | $645K | Buy |
|
|||||
|
2023
Q1 | $204K | Hold |
|
|||||
|
2022
Q4 | $191K | Sell |
|
|||||
|
2022
Q3 | $790K | Hold |
|
|||||
|
2022
Q2 | $733K | Sell |
|
|||||
|
2022
Q1 | $716K | Buy |
|
|||||
|
2021
Q4 | $610K | Buy |
|
|||||
|
2021
Q3 | $530K | Buy |
|
|||||
|
2021
Q2 | $535K | Buy |
|
|||||
|
2021
Q1 | $454K | Sell |
|
|||||
|
2020
Q4 | $2.99M | Sell |
|
|||||
|
2020
Q3 | $2.58M | Sell |
|
|||||
|
2020
Q2 | $5.42M | Sell |
|
|||||
|
2020
Q1 | $4.18M | Buy |
|
|||||
|
2019
Q4 | $2.11M | Sell |
|
|||||
|
2019
Q3 | $2.94M | Sell |
|
|||||
|
2019
Q2 | $3.11M | Sell |
|
|||||
|
2019
Q1 | $4.84M | Buy |
|
|||||
|
2018
Q4 | $2.75M | Sell |
|
|||||
|
2018
Q3 | $20M | Sell |
|
|||||
|
2018
Q2 | $43.8M | Sell |
|
|||||
|
2018
Q1 | $54.5M | Buy |
|
|||||
|
2017
Q4 | $44.8M | Buy |
|
|||||
|
2017
Q3 | $44.3M | Buy |
|
|||||
|
2017
Q2 | $20M | Buy |
|
|||||
|
2017
Q1 | $12.2M | Buy |
|
|||||
|
2016
Q4 | $2.64M | Buy |
|
|||||
|
2016
Q3 | $1.22M | Buy |
|
|||||
|
2016
Q2 | $166K | Sell |
|
|||||
|
2016
Q1 | $290K | Sell |
|
|||||
|
2015
Q4 | $506K | Sell |
|
|||||
|
2015
Q3 | $796K | Buy |
|
|||||
|
2015
Q2 | $287K | Buy |
|